Even though Sepsis is only in healthy volunteers it will still be a huge inflection point to see our product in the blood of humans not causing severe reactions/problems. Will also give us heaps of data around how it is processed by our body....
Then we are one step away from efficacy. If it shows to be efficacious against viral load in blood we will be many many multiples from here...
And yes burns could be a company maker on its own... And of course Sars data coming too and there is still a large need for antivirals in this space. So many irons in the fire!
RCE Price at posting:
99.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)